| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.802 | 0.004 | 0.802 | Aldehyde oxidase inhibitor | 0.195 0.107 CID_86290012 | ||
| 0.755 | 0.017 | 0.755 | Caspase 9 stimulant | |||
| 0.71 | 0.006 | 0.71 | 5 Hydroxytryptamine release stimulant | 0.198 0.123 CID_86290012 | ||
| 0.646 | 0.003 | 0.646 | Tyrosine 3 hydroxylase inhibitor | 0.281 0.044 CID_86290012 | ||
| 0.601 | 0.004 | 0.601 | Peroxidase inhibitor | 0.245 0.048 CID_86290012 | ||
| 0.594 | 0.007 | 0.665 | Superoxide dismutase inhibitor | 0.665 0.005 CID_86290012 | CID_86290012 | |
| 0.589 | 0.02 | 0.646 | Cholesterol antagonist | 0.646 0.013 CID_86290012 | CID_86290012 | |
| 0.571 | 0.015 | 0.571 | 5 Hydroxytryptamine release inhibitor | |||
| 0.566 | 0.012 | 0.566 | GABA C receptor rho-3 antagonist | |||
| 0.527 | 0.004 | 0.527 | 5 Hydroxytryptamine uptake stimulant | 0.282 0.055 CID_86290012 | ||
| 0.525 | 0.004 | 0.525 | Neurotrophic factor enhancer | 0.189 0.088 CID_86290012 | ||
| 0.523 | 0.02 | 0.523 | Calcium channel L-type activator | |||
| 0.524 | 0.022 | 0.524 | Histamine release inhibitor | 0.453 0.049 CID_86290012 | ||
| 0.506 | 0.008 | 0.506 | Anesthetic general | |||
| 0.472 | 0.025 | 0.472 | 12-Lipoxygenase inhibitor | |||
| 0.471 | 0.035 | 0.471 | Vasodilator, peripheral | |||
| 0.477 | 0.046 | 0.477 | 15-Lipoxygenase inhibitor | 0.335 0.108 CID_86290012 | ||
| 0.442 | 0.023 | 0.442 | Free radical scavenger | 0.188 0.108 CID_86290012 | ||
| 0.424 | 0.009 | 0.428 | Phospholipase C inhibitor | 0.428 0.009 CID_86290012 | CID_86290012 | |
| 0.465 | 0.05 | 0.465 | Transcription factor NF kappa B inhibitor | 0.251 0.127 CID_86290012 | ||
| 0.417 | 0.011 | 0.417 | Melanin inhibitor | |||
| 0.433 | 0.029 | 0.448 | Antioxidant | 0.448 0.027 CID_86290012 | CID_86290012 | |
| 0.417 | 0.03 | 0.417 | Vasodilator, coronary | |||
| 0.383 | 0.004 | 0.383 | Alcohol oxidase inhibitor | |||
| 0.38 | 0.004 | 0.38 | Estrogen receptor beta antagonist | 0.103 0.06 CID_86290012 | ||
| 0.4 | 0.025 | 0.4 | Calcium channel activator | 0.259 0.136 CID_86290012 | ||
| 0.393 | 0.019 | 0.393 | Sodium/bile acid cotransporter inhibitor | 0.334 0.051 CID_86290012 | ||
| 0.37 | 0.003 | 0.37 | Phenylalanine 4-hydroxylase inhibitor | 0.121 0.018 CID_86290012 | ||
| 0.398 | 0.038 | 0.398 | Lipoxygenase inhibitor | |||
| 0.364 | 0.005 | 0.364 | Estrogen antagonist | 0.102 0.093 CID_86290012 | ||
| 0.367 | 0.011 | 0.367 | Alpha-N-acetylglucosaminidase inhibitor | 0.115 0.083 CID_86290012 | ||
| 0.382 | 0.025 | 0.382 | Psychostimulant | |||
| 0.357 | 0.006 | 0.357 | Cystathionine beta-synthase inhibitor | |||
| 0.371 | 0.021 | 0.445 | RNA-directed DNA polymerase inhibitor | 0.445 0.014 CID_86290012 | CID_86290012 | |
| 0.379 | 0.031 | 0.379 | Hypoglycemic | |||
| 0.39 | 0.042 | 0.39 | Spasmolytic | 0.308 0.067 CID_86290012 | ||
| 0.333 | 0.006 | 0.333 | Nitric-oxide synthase stimulant | |||
| 0.355 | 0.032 | 0.355 | Insulysin inhibitor | 0.193 0.167 CID_86290012 | ||
| 0.334 | 0.015 | 0.334 | Monophenol monooxygenase inhibitor | 0.153 0.046 CID_86290012 | ||
| 0.322 | 0.005 | 0.322 | GABA C receptor rho-2 antagonist | 0.129 0.107 CID_86290012 | ||
| 0.33 | 0.015 | 0.33 | Amylase inhibitor | |||
| 0.358 | 0.048 | 0.358 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.343 | 0.036 | 0.343 | Amyloid beta aggregation inhibitor | |||
| 0.337 | 0.033 | 0.337 | Interleukin agonist | |||
| 0.321 | 0.018 | 0.321 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.312 | 0.01 | 0.312 | Aldehyde dehydrogenase inhibitor | |||
| 0.331 | 0.031 | 0.331 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.302 | 0.004 | 0.302 | Creatine kinase inhibitor | 0.127 0.036 CID_86290012 | ||
| 0.331 | 0.04 | 0.331 | Pyruvate kinase inhibitor | |||
| 0.34 | 0.05 | 0.34 | Interleukin 2 agonist | |||
| 0.294 | 0.007 | 0.294 | Histidine decarboxylase inhibitor | |||
| 0.366 | 0.079 | 0.366 | Calpain 2 inhibitor | |||
| 0.397 | 0.115 | 0.397 | Apoptosis agonist | |||
| 0.345 | 0.066 | 0.558 | Antithrombotic | 0.558 0.021 CID_86290012 | CID_86290012 | |
| 0.284 | 0.006 | 0.284 | Porphobilinogen synthase inhibitor | 0.113 0.031 CID_86290012 | ||
| 0.29 | 0.012 | 0.29 | Succinate dehydrogenase inhibitor | 0.201 0.048 CID_86290012 | ||
| 0.277 | 0.005 | 0.277 | GABA C receptor antagonist | 0.184 0.017 CID_86290012 | ||
| 0.29 | 0.018 | 0.29 | Insulin sensitizer | 0.226 0.05 CID_86290012 | ||
| 0.278 | 0.008 | 0.278 | Farnesoid X receptor antagonist | 0.135 0.073 CID_86290012 | ||
| 0.286 | 0.021 | 0.286 | Lipid peroxidase inhibitor | 0.164 0.059 CID_86290012 | ||
| 0.32 | 0.057 | 0.32 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.268 | 0.006 | 0.395 | Estrogen agonist | 0.395 0.004 CID_86290012 | CID_86290012 | |
| 0.268 | 0.006 | 0.268 | Alcohol dehydrogenase inhibitor | |||
| 0.263 | 0.003 | 0.263 | DOPA decarboxylase inhibitor | 0.109 0.06 CID_86290012 | ||
| 0.347 | 0.088 | 0.347 | Immunosuppressant | 0.229 0.167 CID_86290012 | ||
| 0.271 | 0.017 | 0.271 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.376 | 0.123 | 0.376 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.257 | 0.005 | 0.257 | TRPA1 agonist | 0.204 0.01 CID_86290012 | ||
| 0.256 | 0.005 | 0.256 | Photosensitizer | 0.136 0.041 CID_86290012 | ||
| 0.267 | 0.017 | 0.267 | NADPH oxidase inhibitor | |||
| 0.268 | 0.019 | 0.268 | Phospholipase A2 inhibitor | 0.203 0.041 CID_86290012 | ||
| 0.272 | 0.024 | 0.272 | Interferon gamma antagonist | |||
| 0.256 | 0.008 | 0.256 | Cyclooxygenase 3 inhibitor | |||
| 0.253 | 0.006 | 0.253 | Estrogen receptor alpha antagonist | 0.072 0.064 CID_86290012 | ||
| 0.279 | 0.033 | 0.279 | Non-steroidal antiinflammatory agent | 0.142 0.127 CID_86290012 | ||
| 0.248 | 0.004 | 0.248 | GABA aminotransferase inhibitor | |||
| 0.296 | 0.053 | 0.296 | Antiamyloidogenic | |||
| 0.298 | 0.055 | 0.298 | Transcription factor STAT3 inhibitor | |||
| 0.255 | 0.013 | 0.255 | GABA C receptor agonist | |||
| 0.251 | 0.009 | 0.251 | Carbonic anhydrase III inhibitor | 0.21 0.015 CID_86290012 | ||
| 0.298 | 0.057 | 0.298 | Transcription factor STAT inhibitor | |||
| 0.283 | 0.042 | 0.283 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.323 | 0.083 | 0.323 | Thyroid hormone antagonist | |||
| 0.252 | 0.012 | 0.252 | Carbonic anhydrase XV inhibitor | 0.129 0.041 CID_86290012 | ||
| 0.356 | 0.118 | 0.411 | Cyclophilin D inhibitor | 0.411 0.085 CID_86290012 | CID_86290012 | |
| 0.253 | 0.016 | 0.253 | Hexokinase inhibitor | |||
| 0.249 | 0.013 | 0.249 | UDP-glucose 4-epimerase inhibitor | |||
| 0.241 | 0.006 | 0.241 | Vanilloid 1 agonist | 0.186 0.016 CID_86290012 | ||
| 0.253 | 0.017 | 0.285 | Cholesterol synthesis inhibitor | 0.285 0.013 CID_86290012 | CID_86290012 | |
| 0.244 | 0.009 | 0.244 | Carbonic anhydrase VI inhibitor | 0.201 0.013 CID_86290012 | ||
| 0.239 | 0.005 | 0.239 | Glutamate decarboxylase inhibitor | 0.097 0.032 CID_86290012 | ||
| 0.238 | 0.005 | 0.238 | GABA C receptor rho-1 antagonist | |||
| 0.252 | 0.021 | 0.252 | Neurotensin receptor agonist | 0.14 0.128 CID_86290012 | ||
| 0.236 | 0.005 | 0.236 | Prolactin inhibitor | |||
| 0.281 | 0.051 | 0.281 | DNA synthesis inhibitor | |||
| 0.235 | 0.006 | 0.235 | HIV-1 integrase (Overall Integration) inhibitor | 0.156 0.023 CID_86290012 | ||
| 0.266 | 0.04 | 0.266 | DNA methyltransferase I inhibitor | |||
| 0.233 | 0.009 | 0.233 | CF transmembrane conductance regulator agonist | |||
| 0.239 | 0.015 | 0.239 | Ferrochelatase inhibitor | |||
| 0.234 | 0.01 | 0.234 | Arachidonic acid antagonist | 0.189 0.044 CID_86290012 | ||
| 0.249 | 0.027 | 0.249 | Protein kinase stimulant | |||
| 0.225 | 0.003 | 0.225 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.113 0.008 CID_86290012 | ||
| 0.333 | 0.112 | 0.454 | Antibacterial | 0.454 0.055 CID_86290012 | CID_86290012 | |
| 0.303 | 0.083 | 0.303 | Apoptosis antagonist | |||
| 0.247 | 0.029 | 0.247 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.222 | 0.004 | 0.222 | Estrogen receptor beta agonist | 0.206 0.004 CID_86290012 | ||
| 0.224 | 0.006 | 0.224 | Adenylate cyclase stimulant | 0.197 0.015 CID_86290012 | ||
| 0.23 | 0.013 | 0.23 | Toll-Like receptor 2 antagonist | |||
| 0.296 | 0.08 | 0.296 | Caspase 3 stimulant | |||
| 0.272 | 0.056 | 0.272 | Gastrin inhibitor | |||
| 0.224 | 0.008 | 0.224 | Antineoplastic alkaloid | |||
| 0.351 | 0.136 | 0.351 | Alpha-glucosidase inhibitor | |||
| 0.23 | 0.016 | 0.23 | Catenin beta inhibitor | |||
| 0.241 | 0.028 | 0.241 | NOS3 expression enhancer | |||
| 0.217 | 0.004 | 0.217 | Estrogen receptor alpha agonist | 0.032 0.025 CID_86290012 | ||
| 0.257 | 0.044 | 0.257 | DNA methylase inhibitor | |||
| 0.267 | 0.056 | 0.267 | Interleukin antagonist | |||
| 0.229 | 0.019 | 0.229 | 5-Lipoxygenase inhibitor | |||
| 0.214 | 0.007 | 0.214 | Macrophage migration inhibitory factor inhibitor | |||
| 0.266 | 0.06 | 0.266 | Hypolipemic | |||
| 0.223 | 0.02 | 0.223 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.293 | 0.091 | 0.293 | Thyroid hormone beta antagonist | |||
| 0.227 | 0.028 | 0.227 | Heat shock protein 90 antagonist | |||
| 0.202 | 0.003 | 0.202 | Estrogen-related receptor beta agonist | 0.088 0.044 CID_86290012 | ||
| 0.232 | 0.033 | 0.232 | Heat shock protein 90 alpha antagonist | |||
| 0.257 | 0.058 | 0.257 | Calpain inhibitor | |||
| 0.207 | 0.009 | 0.264 | NMDA 2 receptor antagonist | 0.264 0.005 CID_86290012 | CID_86290012 | |
| 0.22 | 0.022 | 0.22 | Topoisomerase I inhibitor | |||
| 0.205 | 0.008 | 0.205 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.198 | 0.002 | 0.198 | Dopamine D5 agonist | 0.043 0.024 CID_86290012 | ||
| 0.203 | 0.008 | 0.203 | Keratolytic | |||
| 0.218 | 0.027 | 0.218 | Anesthetic local | |||
| 0.245 | 0.054 | 0.245 | Peptidyltransferase inhibitor | |||
| 0.2 | 0.011 | 0.2 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.204 | 0.015 | 0.204 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.196 | 0.007 | 0.196 | Heat shock protein 70 antagonist | |||
| 0.191 | 0.004 | 0.191 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.21 | 0.024 | 0.21 | Adenylate cyclase inhibitor | |||
| 0.213 | 0.028 | 0.213 | ATPase inhibitor | |||
| 0.202 | 0.022 | 0.202 | Interleukin 4 antagonist | |||
| 0.248 | 0.07 | 0.248 | Vasodilator | |||
| 0.234 | 0.056 | 0.234 | Nitric oxide antagonist | |||
| 0.191 | 0.015 | 0.191 | Interleukin 8 antagonist | |||
| 0.192 | 0.015 | 0.192 | NMDA receptor antagonist | 0.157 0.022 CID_86290012 | ||
| 0.22 | 0.044 | 0.22 | Histone acetyltransferase inhibitor | |||
| 0.207 | 0.032 | 0.207 | Insulin secretagoues | |||
| 0.186 | 0.011 | 0.186 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.215 | 0.041 | 0.215 | 5 Hydroxytryptamine 3E antagonist | 0.173 0.126 CID_86290012 | ||
| 0.185 | 0.013 | 0.185 | Phosphofructokinase-1 inhibitor | 0.096 0.033 CID_86290012 | ||
| 0.239 | 0.067 | 0.239 | Neuropeptide Y2 antagonist | |||
| 0.179 | 0.009 | 0.179 | Adrenaline agonist | |||
| 0.193 | 0.023 | 0.223 | Aminopeptidase B inhibitor | 0.223 0.017 CID_86290012 | CID_86290012 | |
| 0.176 | 0.009 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.13 0.119 CID_86290012 | ||
| 0.192 | 0.026 | 0.192 | Chelator | |||
| 0.319 | 0.153 | 0.319 | DNA directed DNA polymerase inhibitor | |||
| 0.171 | 0.005 | 0.171 | Bile acid receptor antagonist | 0.156 0.007 CID_86290012 | ||
| 0.209 | 0.043 | 0.464 | Protein-tyrosine phosphatase inhibitor | 0.464 0.005 CID_86290012 | CID_86290012 | |
| 0.182 | 0.018 | 0.182 | Mucolytic | |||
| 0.257 | 0.093 | 0.32 | Immunostimulant | 0.32 0.073 CID_86290012 | CID_86290012 | |
| 0.26 | 0.097 | 0.26 | Streptokinase A inhibitor | |||
| 0.177 | 0.016 | 0.177 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.201 | 0.04 | 0.201 | Interleukin 6 antagonist | |||
| 0.178 | 0.017 | 0.409 | Carbonic anhydrase XIII inhibitor | 0.409 0.004 CID_86290012 | CID_86290012 | |
| 0.213 | 0.054 | 0.213 | Growth hormone agonist | |||
| 0.19 | 0.031 | 0.19 | MAO A inhibitor | |||
| 0.173 | 0.015 | 0.502 | Triose-phosphate isomerase inhibitor | 0.502 0.002 CID_86290012 | CID_86290012 | |
| 0.194 | 0.035 | 0.234 | Alkaline phosphatase inhibitor | 0.234 0.024 CID_86290012 | CID_86290012 | |
| 0.167 | 0.011 | 0.173 | Anabolic | 0.173 0.009 CID_86290012 | CID_86290012 | |
| 0.162 | 0.006 | 0.162 | NMDA 2A receptor antagonist | 0.078 0.02 CID_86290012 | ||
| 0.212 | 0.058 | 0.212 | Sigma receptor agonist | |||
| 0.179 | 0.026 | 0.179 | Expectorant | |||
| 0.174 | 0.026 | 0.174 | Xanthine oxidase inhibitor | |||
| 0.156 | 0.01 | 0.156 | Vanilloid agonist | 0.104 0.029 CID_86290012 | ||
| 0.153 | 0.008 | 0.153 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.201 | 0.057 | 0.201 | Amyloid beta precursor protein antagonist | |||
| 0.163 | 0.02 | 0.163 | Sphingomyelinase inhibitor | |||
| 0.203 | 0.059 | 0.504 | Dual specificity phosphatase 3 inhibitor | 0.504 0.007 CID_86290012 | CID_86290012 | |
| 0.168 | 0.026 | 0.168 | Bronchodilator | |||
| 0.186 | 0.045 | 0.186 | MAO inhibitor | |||
| 0.176 | 0.037 | 0.176 | DNA polymerase I inhibitor | |||
| 0.145 | 0.006 | 0.145 | NMDA receptor subunit 3B antagonist | |||
| 0.153 | 0.015 | 0.153 | CYP2A6 inhibitor | |||
| 0.144 | 0.006 | 0.144 | Beta 3 adrenoreceptor antagonist | 0.062 0.049 CID_86290012 | ||
| 0.259 | 0.122 | 0.259 | Prostaglandin dehydrogenase inhibitor | |||
| 0.22 | 0.084 | 0.542 | Angiogenesis stimulant | 0.542 0.009 CID_86290012 | CID_86290012 | |
| 0.163 | 0.029 | 0.163 | 5 Hydroxytryptamine 3A agonist | |||
| 0.16 | 0.026 | 0.16 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.193 | 0.058 | 0.485 | Dual specificity phosphatase inhibitor | 0.485 0.007 CID_86290012 | CID_86290012 | |
| 0.157 | 0.024 | 0.157 | Opioid antagonist | |||
| 0.164 | 0.031 | 0.164 | Microtubule formation inhibitor | |||
| 0.14 | 0.008 | 0.14 | Purinergic P2X1 antagonist | 0.07 0.032 CID_86290012 | ||
| 0.14 | 0.008 | 0.14 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.201 | 0.07 | 0.459 | Platelet adhesion inhibitor | 0.459 0.007 CID_86290012 | CID_86290012 | |
| 0.153 | 0.022 | 0.153 | Urease inhibitor | |||
| 0.138 | 0.007 | 0.138 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.169 | 0.039 | 0.289 | Protein-tyrosine phosphatase 1B inhibitor | 0.289 0.012 CID_86290012 | CID_86290012 | |
| 0.167 | 0.037 | 0.167 | Nav1.6 sodium channel blocker | |||
| 0.188 | 0.058 | 0.188 | Antipruritic | |||
| 0.166 | 0.036 | 0.166 | Cathepsin H inhibitor | 0.11 0.09 CID_86290012 | ||
| 0.143 | 0.014 | 0.143 | Aminopeptidase I inhibitor | |||
| 0.151 | 0.022 | 0.151 | Androgen antagonist | |||
| 0.13 | 0.005 | 0.13 | GABA B receptor agonist | |||
| 0.143 | 0.019 | 0.143 | NADH dehydrogenase inhibitor | 0.088 0.059 CID_86290012 | ||
| 0.149 | 0.027 | 0.149 | Adenylate kinase inhibitor | 0.104 0.062 CID_86290012 | ||
| 0.192 | 0.07 | 0.192 | P-glycoprotein inhibitor | |||
| 0.169 | 0.047 | 0.169 | Bone formation stimulant | |||
| 0.128 | 0.006 | 0.128 | NMDA receptor subunit 3A antagonist | |||
| 0.187 | 0.066 | 0.187 | Lipocortins synthesis antagonist | |||
| 0.22 | 0.1 | 0.22 | DNA damaging | |||
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.136 | 0.018 | 0.337 | Carbonic anhydrase V inhibitor | 0.337 0.003 CID_86290012 | CID_86290012 | |
| 0.129 | 0.011 | 0.233 | Carbonic anhydrase VB inhibitor | 0.233 0.004 CID_86290012 | CID_86290012 | |
| 0.167 | 0.049 | 0.167 | Cyclooxygenase 1 inhibitor | 0.154 0.054 CID_86290012 | ||
| 0.164 | 0.046 | 0.164 | Neuropeptide Y1 antagonist | |||
| 0.13 | 0.013 | 0.13 | Leukotriene antagonist | 0.099 0.022 CID_86290012 | ||
| 0.125 | 0.009 | 0.125 | Beta adrenoreceptor antagonist | |||
| 0.128 | 0.012 | 0.128 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.125 | 0.01 | 0.125 | NMDA 2C receptor antagonist | 0.103 0.015 CID_86290012 | ||
| 0.144 | 0.028 | 0.144 | Transcription factor STAT6 inhibitor | |||
| 0.12 | 0.005 | 0.12 | Sphingosine kinase 2 inhibitor | |||
| 0.139 | 0.024 | 0.201 | Acetylcholine release stimulant | 0.201 0.005 CID_86290012 | CID_86290012 | |
| 0.173 | 0.058 | 0.566 | Diuretic | 0.566 0.005 CID_86290012 | CID_86290012 | |
| 0.188 | 0.073 | 0.217 | Hepatoprotectant | 0.217 0.055 CID_86290012 | CID_86290012 | |
| 0.15 | 0.036 | 0.15 | Falcipain 3 inhibitor | |||
| 0.135 | 0.022 | 0.135 | Opioid delta receptor antagonist | |||
| 0.121 | 0.008 | 0.121 | CC chemokine 5 receptor agonist | 0.105 0.016 CID_86290012 | ||
| 0.285 | 0.173 | 0.285 | DNA polymerase beta inhibitor | |||
| 0.124 | 0.012 | 0.124 | D-Ala-D-Ala ligase inhibitor | |||
| 0.162 | 0.05 | 0.174 | Nav1.2 sodium channel blocker | 0.174 0.045 CID_86290012 | CID_86290012 | |
| 0.13 | 0.019 | 0.13 | Ornithine decarboxylase inhibitor | |||
| 0.115 | 0.004 | 0.115 | Nicotinic acid receptor agonist | |||
| 0.143 | 0.033 | 0.143 | AMP-activated protein kinase stimulant | |||
| 0.16 | 0.05 | 0.16 | M17 leucyl aminopeptidase inhibitor | |||
| 0.138 | 0.029 | 0.186 | Catalase inhibitor | 0.186 0.018 CID_86290012 | CID_86290012 | |
| 0.139 | 0.031 | 0.139 | Beta glucuronidase inhibitor | |||
| 0.153 | 0.045 | 0.153 | Proteasome inhibitor | |||
| 0.149 | 0.041 | 0.149 | Beta amyloid protein antagonist | |||
| 0.111 | 0.004 | 0.111 | Adenylate cyclase 1 inhibitor | |||
| 0.13 | 0.022 | 0.13 | Opioid mu receptor antagonist | |||
| 0.143 | 0.036 | 0.143 | Nav1.1 sodium channel blocker | |||
| 0.128 | 0.021 | 0.128 | Opioid kappa receptor antagonist | |||
| 0.124 | 0.017 | 0.239 | Carbonic anhydrase VA inhibitor | 0.239 0.004 CID_86290012 | CID_86290012 | |
| 0.113 | 0.006 | 0.113 | Potassium channel Kv1.3 blocker | |||
| 0.126 | 0.02 | 0.14 | HIV-1 reverse transcriptase inhibitor | 0.14 0.016 CID_86290012 | CID_86290012 | |
| 0.113 | 0.008 | 0.129 | Leukotriene B4 antagonist | 0.129 0.006 CID_86290012 | CID_86290012 | |
| 0.124 | 0.019 | 0.124 | Purinergic P2X2 antagonist | 0.084 0.038 CID_86290012 | ||
| 0.129 | 0.024 | 0.129 | Histamine N-methyltransferase inhibitor | |||
| 0.153 | 0.048 | 0.153 | Pregnane X receptor agonist | 0.123 0.121 CID_86290012 | ||
| 0.129 | 0.025 | 0.314 | Cathepsin G inhibitor | 0.314 0.009 CID_86290012 | CID_86290012 | |
| 0.114 | 0.01 | 0.114 | 5 Hydroxytryptamine 2A agonist | |||
| 0.136 | 0.033 | 0.204 | Gastric antisecretory | 0.204 0.011 CID_86290012 | CID_86290012 | |
| 0.175 | 0.072 | 0.175 | Tumour necrosis factor antagonist | |||
| 0.111 | 0.008 | 0.111 | Beta 1 adrenoreceptor antagonist | |||
| 0.157 | 0.055 | 0.157 | Tubulin antagonist | |||
| 0.106 | 0.005 | 0.106 | Calcium channel P-type blocker | 0.061 0.052 CID_86290012 | ||
| 0.107 | 0.007 | 0.107 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.107 | 0.008 | 0.107 | MAP kinase kinase 7 inhibitor | |||
| 0.106 | 0.007 | 0.106 | Beta 2 adrenoreceptor antagonist | |||
| 0.204 | 0.106 | 0.204 | Tumour necrosis factor alpha release inhibitor | |||
| 0.126 | 0.027 | 0.126 | Thioredoxin inhibitor | |||
| 0.162 | 0.064 | 0.162 | Acetylcholine M1 receptor antagonist | |||
| 0.13 | 0.032 | 0.13 | Uric acid excretion stimulant | |||
| 0.117 | 0.02 | 0.168 | Glycine receptor antagonist | 0.168 0.005 CID_86290012 | CID_86290012 | |
| 0.128 | 0.031 | 0.128 | Electrolyte absorption antagonist | |||
| 0.169 | 0.074 | 0.169 | Mcl-1 antagonist | |||
| 0.117 | 0.021 | 0.117 | Myeloperoxidase inhibitor | |||
| 0.167 | 0.072 | 0.167 | Death-associated protein kinase 2 inhibitor | |||
| 0.102 | 0.007 | 0.14 | Sphingosine kinase inhibitor | 0.14 0.004 CID_86290012 | CID_86290012 | |
| 0.162 | 0.067 | 0.162 | Cytidine deaminase inhibitor | |||
| 0.1 | 0.005 | 0.1 | Squalene epoxidase inhibitor | |||
| 0.104 | 0.01 | 0.104 | Heat shock protein 90 beta antagonist | |||
| 0.119 | 0.025 | 0.152 | Inducible nitric-oxide synthase inhibitor | 0.152 0.016 CID_86290012 | CID_86290012 | |
| 0.106 | 0.012 | 0.106 | Glycine transporter 2 inhibitor | |||
| 0.109 | 0.016 | 0.109 | Glycine receptor agonist | |||
| 0.097 | 0.005 | 0.097 | Dihydroorotate oxidase inhibitor | 0.055 0.037 CID_86290012 | ||
| 0.105 | 0.013 | 0.105 | Androgen agonist | 0.084 0.022 CID_86290012 | ||
| 0.108 | 0.017 | 0.108 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.128 | 0.038 | 0.128 | Electron transport complex I inhibitor | |||
| 0.125 | 0.036 | 0.174 | Breast cancer-resistant protein inhibitor | 0.174 0.018 CID_86290012 | CID_86290012 | |
| 0.111 | 0.023 | 0.111 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.142 | 0.053 | 0.142 | Topoisomerase II inhibitor | |||
| 0.114 | 0.025 | 0.114 | Analgesic, opioid | |||
| 0.142 | 0.054 | 0.142 | Antibacterial (Helicobacter pylori) | 0.136 0.06 CID_86290012 | ||
| 0.113 | 0.025 | 0.113 | Glutamate dehydrogenase inhibitor | 0.066 0.063 CID_86290012 | ||
| 0.099 | 0.011 | 0.099 | Glutamate (mGluR7) antagonist | |||
| 0.091 | 0.005 | 0.091 | Beta 2 adrenoreceptor agonist | 0.06 0.049 CID_86290012 | ||
| 0.115 | 0.03 | 0.115 | Phosphodiesterase 6D inhibitor | 0.091 0.073 CID_86290012 | ||
| 0.121 | 0.037 | 0.121 | Nitric-oxide synthase inhibitor | 0.118 0.039 CID_86290012 | ||
| 0.15 | 0.066 | 0.272 | Cell wall synthesis inhibitor | 0.272 0.012 CID_86290012 | CID_86290012 | |
| 0.087 | 0.005 | 0.087 | Pregnane X receptor antagonist | |||
| 0.115 | 0.034 | 0.115 | Interleukin 12 antagonist | |||
| 0.099 | 0.019 | 0.099 | Biliverdin reductase inhibitor | |||
| 0.121 | 0.04 | 0.121 | Potassium channel (Ca-activated) activator | |||
| 0.084 | 0.004 | 0.084 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.096 | 0.017 | 0.096 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.134 | 0.056 | 0.134 | CC chemokine 6 receptor antagonist | |||
| 0.143 | 0.065 | 0.143 | Neurotrophic factor | |||
| 0.102 | 0.025 | 0.353 | HIV-1 integrase (3'-Processing) inhibitor | 0.353 0.004 CID_86290012 | CID_86290012 | |
| 0.082 | 0.005 | 0.082 | Dopamine beta hydroxylase inhibitor | |||
| 0.083 | 0.006 | 0.083 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.081 | 0.004 | 0.081 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.047 0.019 CID_86290012 | ||
| 0.147 | 0.071 | 0.444 | Hemostatic | 0.444 0.005 CID_86290012 | CID_86290012 | |
| 0.093 | 0.017 | 0.093 | Alpha 2 adrenoreceptor agonist | |||
| 0.095 | 0.02 | 0.095 | Argininosuccinate synthase inhibitor | |||
| 0.13 | 0.055 | 0.13 | DNA repair enzyme inhibitor | |||
| 0.093 | 0.019 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.057 CID_86290012 | ||
| 0.123 | 0.049 | 0.123 | MAO B inhibitor | |||
| 0.078 | 0.004 | 0.078 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.294 | 0.221 | 0.398 | Antiinflammatory | 0.398 0.14 CID_86290012 | CID_86290012 | |
| 0.108 | 0.036 | 0.108 | Alpha 2d adrenoreceptor antagonist | |||
| 0.094 | 0.023 | 0.094 | Aromatase inhibitor | 0.063 0.039 CID_86290012 | ||
| 0.088 | 0.017 | 0.088 | Alpha tubulin antagonist | |||
| 0.254 | 0.184 | 0.254 | Transcription factor inhibitor | |||
| 0.083 | 0.013 | 0.083 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.078 | 0.009 | 0.078 | Leukotriene C antagonist | |||
| 0.094 | 0.024 | 0.094 | Beta tubulin antagonist | |||
| 0.089 | 0.021 | 0.089 | TRPA1 antagonist | |||
| 0.09 | 0.022 | 0.09 | Potassium channel Kv1.5 blocker | |||
| 0.074 | 0.006 | 0.074 | GABA uptake inhibitor | |||
| 0.071 | 0.004 | 0.071 | Uridine phosphorylase inhibitor | 0.039 0.012 CID_86290012 | ||
| 0.071 | 0.004 | 0.071 | Estrogen-related receptor beta antagonist | |||
| 0.075 | 0.008 | 0.075 | Immunoglobulin Fc receptor antagonist | |||
| 0.08 | 0.014 | 0.08 | Aconitate hydratase inhibitor | |||
| 0.074 | 0.008 | 0.074 | Liver X receptor alpha agonist | |||
| 0.143 | 0.077 | 0.143 | Thiol protease inhibitor | |||
| 0.098 | 0.033 | 0.098 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.082 | 0.017 | 0.082 | Opioid mu receptor agonist | |||
| 0.068 | 0.003 | 0.069 | Thyroid hormone agonist | 0.069 0.003 CID_86290012 | CID_86290012 | |
| 0.081 | 0.017 | 0.081 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.098 | 0.034 | 0.101 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 CID_86290012 | CID_86290012 | |
| 0.103 | 0.039 | 0.103 | Glutamate release inhibitor | |||
| 0.126 | 0.062 | 0.126 | Alkylator | |||
| 0.114 | 0.05 | 0.114 | Toll-Like receptor 4 antagonist | |||
| 0.086 | 0.023 | 0.086 | Potassium channel (ATP-sensitive) blocker | |||
| 0.083 | 0.021 | 0.083 | Glutamate (mGluR6) antagonist | |||
| 0.069 | 0.006 | 0.069 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.074 | 0.012 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.052 0.032 CID_86290012 | ||
| 0.072 | 0.01 | 0.072 | Urate transporter 1 inhibitor | |||
| 0.07 | 0.008 | 0.07 | Geranyltranstransferase inhibitor | |||
| 0.066 | 0.004 | 0.066 | Sodium/glucose cotransporter inhibitor | |||
| 0.099 | 0.038 | 0.099 | Glutathione S-transferase inhibitor | |||
| 0.073 | 0.012 | 0.073 | Vanilloid 2 antagonist | 0.048 0.047 CID_86290012 | ||
| 0.069 | 0.009 | 0.069 | Retinoid X alpha receptor agonist | |||
| 0.085 | 0.026 | 0.085 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.104 | 0.045 | 0.104 | ABCA1 expression enhancer | |||
| 0.073 | 0.014 | 0.073 | Ryanodine receptor antagonist | |||
| 0.119 | 0.061 | 0.119 | Caspase 3 inhibitor | |||
| 0.083 | 0.025 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | 0.089 0.021 CID_86290012 | CID_86290012 | |
| 0.079 | 0.023 | 0.079 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.063 | 0.007 | 0.063 | Beta adrenoreceptor agonist | |||
| 0.106 | 0.049 | 0.106 | Glutamate (mGluR7) agonist | |||
| 0.072 | 0.016 | 0.085 | Alpha-mannosidase inhibitor | 0.085 0.009 CID_86290012 | CID_86290012 | |
| 0.061 | 0.005 | 0.061 | Liver X receptor beta antagonist | |||
| 0.133 | 0.077 | 0.133 | Histone deacetylase SIRT1 inhibitor | |||
| 0.065 | 0.01 | 0.065 | Nicotinic acid receptor 2 agonist | |||
| 0.071 | 0.016 | 0.071 | Topoisomerase II beta inhibitor | |||
| 0.187 | 0.132 | 0.187 | Cardiotonic | |||
| 0.105 | 0.051 | 0.105 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.063 | 0.009 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 CID_86290012 | CID_86290012 | |
| 0.066 | 0.012 | 0.066 | Retinoid X receptor agonist | |||
| 0.071 | 0.017 | 0.071 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.076 | 0.022 | 0.076 | Phosphodiesterase 1C inhibitor | |||
| 0.087 | 0.033 | 0.121 | HIV-1 integrase inhibitor | 0.121 0.015 CID_86290012 | CID_86290012 | |
| 0.077 | 0.023 | 0.077 | MDM2 inhibitor | |||
| 0.087 | 0.034 | 0.087 | Alpha adrenoreceptor agonist | |||
| 0.072 | 0.019 | 0.072 | Carbonic anhydrase XIV inhibitor | |||
| 0.112 | 0.059 | 0.112 | Protein kinase C gamma inhibitor | |||
| 0.084 | 0.031 | 0.084 | Secretase beta inhibitor | |||
| 0.11 | 0.058 | 0.11 | Mediator release inhibitor | |||
| 0.079 | 0.027 | 0.079 | Exportin-1 inhibitor | |||
| 0.065 | 0.013 | 0.065 | Oxytocin agonist | |||
| 0.083 | 0.031 | 0.083 | Dopamine D1 antagonist | |||
| 0.058 | 0.007 | 0.058 | Heme oxygenase inhibitor | |||
| 0.062 | 0.011 | 0.062 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.081 | 0.03 | 0.314 | HIV-1 integrase (Strand Transfer) inhibitor | 0.314 0.005 CID_86290012 | CID_86290012 | |
| 0.056 | 0.006 | 0.056 | ATP citrate lysase inhibitor | |||
| 0.079 | 0.029 | 0.108 | NMDA receptor agonist | 0.108 0.016 CID_86290012 | CID_86290012 | |
| 0.118 | 0.069 | 0.118 | Acetylcholine muscarinic antagonist | |||
| 0.056 | 0.007 | 0.056 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.062 | 0.012 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.086 | 0.037 | 0.086 | Lipase inhibitor | |||
| 0.09 | 0.041 | 0.09 | Somatostatin 1 agonist | |||
| 0.064 | 0.015 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.045 0.039 CID_86290012 | ||
| 0.072 | 0.024 | 0.072 | Fatty acid synthase inhibitor | |||
| 0.052 | 0.003 | 0.052 | Estrogen-related receptor gamma antagonist | 0.027 0.023 CID_86290012 | ||
| 0.088 | 0.04 | 0.088 | Interferon agonist | 0.083 0.048 CID_86290012 | ||
| 0.062 | 0.015 | 0.062 | Sphingosine 1-phosphate receptor agonist | |||
| 0.078 | 0.03 | 0.078 | NMDA receptor glycine site agonist | |||
| 0.063 | 0.016 | 0.063 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.053 | 0.006 | 0.053 | Leukotriene B4 receptor 1 antagonist | |||
| 0.064 | 0.017 | 0.064 | Adenosine deaminase inhibitor | 0.05 0.03 CID_86290012 | ||
| 0.056 | 0.01 | 0.056 | Glutamate (mGluR3) antagonist | |||
| 0.062 | 0.016 | 0.062 | Cholesterol esterase inhibitor | |||
| 0.05 | 0.004 | 0.05 | Nicotinic acid receptor 2 antagonist | |||
| 0.058 | 0.012 | 0.058 | Alpha 1d adrenoreceptor agonist | |||
| 0.072 | 0.026 | 0.072 | Transcription factor RelA inhibitor | |||
| 0.087 | 0.042 | 0.087 | Ca(v)3.1 blocker | |||
| 0.053 | 0.008 | 0.053 | Leukotriene C4 antagonist | |||
| 0.068 | 0.023 | 0.068 | Glucosylceramidase inhibitor | |||
| 0.071 | 0.027 | 0.071 | Cyclin D1 inhibitor | |||
| 0.061 | 0.016 | 0.077 | Mannosidase inhibitor | 0.077 0.009 CID_86290012 | CID_86290012 | |
| 0.071 | 0.026 | 0.071 | Histone deacetylase SIRT3 inhibitor | |||
| 0.063 | 0.018 | 0.063 | CXC chemokine 1 receptor antagonist | |||
| 0.056 | 0.012 | 0.056 | Sphingosine kinase 1 inhibitor | |||
| 0.07 | 0.026 | 0.07 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.103 | 0.059 | 0.103 | Folate antagonist | |||
| 0.074 | 0.03 | 0.074 | Interferon inducer | 0.07 0.034 CID_86290012 | ||
| 0.055 | 0.012 | 0.055 | Estrogen-related receptor alpha antagonist | |||
| 0.069 | 0.026 | 0.437 | NMDA 2B receptor antagonist | 0.437 0.004 CID_86290012 | CID_86290012 | |
| 0.081 | 0.038 | 0.081 | Vanilloid 4 agonist | |||
| 0.067 | 0.025 | 0.067 | Cannabinoid CB2 receptor antagonist | |||
| 0.053 | 0.011 | 0.053 | Kainate receptor agonist | |||
| 0.072 | 0.03 | 0.072 | Carbonic anhydrase stimulant | |||
| 0.046 | 0.003 | 0.046 | Vanilloid 2 agonist | 0.042 0.004 CID_86290012 | ||
| 0.045 | 0.003 | 0.045 | Estrogen-related receptor gamma agonist | |||
| 0.063 | 0.021 | 0.063 | Glucose-6-phosphate translocase inhibitor | |||
| 0.052 | 0.01 | 0.052 | Glutamate (mGluR8) agonist | |||
| 0.046 | 0.005 | 0.046 | Leukotriene B4 receptor 2 antagonist | |||
| 0.07 | 0.029 | 0.07 | Maillard reaction inhibitor | |||
| 0.077 | 0.035 | 0.077 | Protein kinase C beta inhibitor | |||
| 0.047 | 0.006 | 0.047 | Glutamate (mGluR3) agonist | |||
| 0.05 | 0.009 | 0.05 | Free fatty acid receptor 1 antagonist | |||
| 0.054 | 0.014 | 0.075 | Dihydrofolate reductase inhibitor | 0.075 0.005 CID_86290012 | CID_86290012 | |
| 0.054 | 0.014 | 0.054 | Dihydropteroate synthase inhibitor | |||
| 0.081 | 0.041 | 0.081 | Adenosine A3 receptor antagonist | |||
| 0.048 | 0.008 | 0.057 | Cholesterol ester transfer protein antagonist | 0.057 0.005 CID_86290012 | CID_86290012 | |
| 0.065 | 0.026 | 0.065 | Opioid agonist | |||
| 0.093 | 0.054 | 0.093 | Phosphodiesterase I inhibitor | |||
| 0.062 | 0.023 | 0.062 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.07 | 0.031 | 0.07 | Acetylcholine M3 receptor antagonist | |||
| 0.102 | 0.064 | 0.102 | Alpha 2c adrenoreceptor antagonist | |||
| 0.077 | 0.04 | 0.077 | Amidase inhibitor | |||
| 0.048 | 0.011 | 0.048 | CF transmembrane conductance regulator antagonist | |||
| 0.062 | 0.026 | 0.062 | Epithelial sodium channel blocker | |||
| 0.069 | 0.032 | 0.069 | Xanthine dehydrogenase inhibitor | |||
| 0.049 | 0.014 | 0.049 | Fumarate hydratase inhibitor | |||
| 0.055 | 0.019 | 0.055 | Purinergic P2X4 antagonist | |||
| 0.057 | 0.021 | 0.057 | Carbonic anhydrase VII inhibitor | |||
| 0.046 | 0.01 | 0.046 | Catechol O-methyltransferase inhibitor | |||
| 0.039 | 0.003 | 0.039 | Nicotinic acid receptor 1 antagonist | |||
| 0.056 | 0.02 | 0.334 | Leukocyte elastase inhibitor | 0.334 0.003 CID_86290012 | CID_86290012 | |
| 0.047 | 0.012 | 0.047 | Liver X receptor beta agonist | |||
| 0.052 | 0.017 | 0.056 | Thymidine kinase inhibitor | 0.056 0.015 CID_86290012 | CID_86290012 | |
| 0.071 | 0.036 | 0.071 | Aryl hydrocarbon receptor antagonist | |||
| 0.09 | 0.055 | 0.09 | Calcium antagonist | |||
| 0.09 | 0.056 | 0.09 | ATPase (Vacuolar H+) inhibitor | |||
| 0.061 | 0.027 | 0.061 | Sigma receptor antagonist | |||
| 0.056 | 0.023 | 0.056 | Aldosterone antagonist | |||
| 0.048 | 0.014 | 0.048 | Retinoid X receptor antagonist | |||
| 0.048 | 0.015 | 0.048 | Potassium channel Kv1.1 blocker | |||
| 0.048 | 0.016 | 0.048 | Diamine oxidase inhibitor | |||
| 0.058 | 0.026 | 0.089 | Heparanase inhibitor | 0.089 0.005 CID_86290012 | CID_86290012 | |
| 0.093 | 0.061 | 0.112 | Protein kinase C zeta inhibitor | 0.112 0.039 CID_86290012 | CID_86290012 | |
| 0.073 | 0.042 | 0.073 | Leukotriene synthesis inhibitor | |||
| 0.065 | 0.034 | 0.065 | Heme oxygenase stimulant | |||
| 0.043 | 0.012 | 0.043 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.043 | 0.012 | 0.043 | Prostaglandin agonist | |||
| 0.059 | 0.029 | 0.1 | Adenine nucleotide translocase inhibitor | 0.1 0.005 CID_86290012 | CID_86290012 | |
| 0.054 | 0.025 | 0.054 | Factor III inhibitor | |||
| 0.062 | 0.033 | 0.062 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.124 | 0.094 | 0.124 | Cyclooxygenase inhibitor | |||
| 0.048 | 0.02 | 0.048 | Angiotensin AT1 receptor antagonist | |||
| 0.063 | 0.035 | 0.063 | Ribonucleotide reductase inhibitor | |||
| 0.074 | 0.045 | 0.088 | Phospholipase D inhibitor | 0.088 0.024 CID_86290012 | CID_86290012 | |
| 0.035 | 0.007 | 0.035 | Prostaglandin F2 alpha agonist | |||
| 0.043 | 0.015 | 0.043 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.068 | 0.04 | 0.068 | CDC25B inhibitor | |||
| 0.045 | 0.018 | 0.045 | 5 Hydroxytryptamine 2B agonist | |||
| 0.08 | 0.053 | 0.08 | Topoisomerase II alpha inhibitor | |||
| 0.04 | 0.013 | 0.04 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.076 | 0.049 | 0.076 | Phosphodiesterase VI inhibitor | |||
| 0.052 | 0.025 | 0.052 | Cytokine production stimulant | |||
| 0.037 | 0.011 | 0.037 | Liver X receptor alpha antagonist | |||
| 0.102 | 0.075 | 0.313 | Multidrug resistance-associated protein 1 inhibitor | 0.313 0.004 CID_86290012 | CID_86290012 | |
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | 0.044 0.017 CID_86290012 | ||
| 0.036 | 0.01 | 0.036 | Prostaglandin EP2 agonist | |||
| 0.156 | 0.131 | 0.156 | Aryl hydrocarbon receptor agonist | |||
| 0.029 | 0.004 | 0.029 | Antibiotic Anthracycline-like | |||
| 0.042 | 0.018 | 0.042 | Opioid delta receptor agonist | |||
| 0.058 | 0.034 | 0.058 | 5 Hydroxytryptamine 7 agonist | |||
| 0.029 | 0.005 | 0.029 | Alpha 2a adrenoreceptor agonist | |||
| 0.082 | 0.057 | 0.082 | Thioredoxin reductase inhibitor | |||
| 0.032 | 0.007 | 0.032 | Beta 1 adrenoreceptor agonist | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.037 | 0.013 | 0.037 | Purinergic P2Y14 antagonist | |||
| 0.05 | 0.027 | 0.05 | Oleamide hydrolase inhibitor | |||
| 0.062 | 0.039 | 0.062 | Prostaglandin EP2 antagonist | |||
| 0.032 | 0.009 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.008 CID_86290012 | CID_86290012 | |
| 0.028 | 0.005 | 0.028 | Alpha 2b adrenoreceptor agonist | |||
| 0.053 | 0.03 | 0.053 | Bombesin 2 receptor antagonist | |||
| 0.099 | 0.076 | 0.099 | Alpha 2b adrenoreceptor antagonist | |||
| 0.032 | 0.01 | 0.032 | Hedgehog signaling activator | |||
| 0.026 | 0.003 | 0.026 | Thyroid hormone beta agonist | |||
| 0.056 | 0.034 | 0.056 | Thromboxane synthase inhibitor | |||
| 0.108 | 0.086 | 0.108 | Cholinergic antagonist | |||
| 0.029 | 0.007 | 0.029 | Prostaglandin EP4 agonist | |||
| 0.059 | 0.038 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.132 | 0.111 | 0.132 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.026 | 0.005 | 0.026 | NMDA receptor phencyclidine site antagonist | |||
| 0.032 | 0.012 | 0.032 | CXC chemokine 2 receptor antagonist | |||
| 0.099 | 0.078 | 0.155 | Nav1.4 sodium channel blocker | 0.155 0.032 CID_86290012 | CID_86290012 | |
| 0.083 | 0.062 | 0.083 | mTOR complex 2 inhibitor | |||
| 0.041 | 0.02 | 0.041 | Vanilloid 3 antagonist | |||
| 0.047 | 0.026 | 0.047 | AICAR transformylase inhibitor | 0.04 0.038 CID_86290012 | ||
| 0.077 | 0.056 | 0.077 | Metalloproteinase-2 inhibitor | |||
| 0.056 | 0.035 | 0.056 | DNA helicase inhibitor | |||
| 0.087 | 0.067 | 0.087 | Polo-like kinase-1 inhibitor | |||
| 0.03 | 0.01 | 0.03 | Prostaglandin E2 agonist | |||
| 0.067 | 0.047 | 0.067 | Dopamine agonist | 0.061 0.051 CID_86290012 | ||
| 0.029 | 0.009 | 0.041 | Dopamine D1 agonist | 0.041 0.005 CID_86290012 | CID_86290012 | |
| 0.035 | 0.015 | 0.035 | Sigma 1 receptor antagonist | |||
| 0.036 | 0.016 | 0.036 | Liver X receptor antagonist | |||
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | |||
| 0.026 | 0.007 | 0.026 | Neuraminidase (Influenza B) inhibitor | |||
| 0.037 | 0.018 | 0.037 | Angiotensin II receptor antagonist | |||
| 0.028 | 0.009 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.042 | 0.023 | 0.042 | 5-Alpha-reductase inhibitor | |||
| 0.105 | 0.086 | 0.105 | Acetylcholine antagonist | |||
| 0.025 | 0.006 | 0.025 | Ileal bile acid transport inhibitor | |||
| 0.06 | 0.042 | 0.06 | Phosphodiesterase 1B inhibitor | |||
| 0.077 | 0.058 | 0.077 | Acetylcholine nicotinic antagonist | |||
| 0.071 | 0.053 | 0.071 | Metalloproteinase-9 inhibitor | |||
| 0.041 | 0.023 | 0.046 | Farnesoid X receptor agonist | 0.046 0.017 CID_86290012 | CID_86290012 | |
| 0.03 | 0.012 | 0.03 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.042 | 0.024 | 0.042 | AMPA 4 receptor antagonist | |||
| 0.051 | 0.033 | 0.051 | CD45 antagonist | |||
| 0.025 | 0.008 | 0.025 | Retinoid X beta receptor antagonist | |||
| 0.022 | 0.005 | 0.022 | Thyroid hormone alpha agonist | |||
| 0.069 | 0.053 | 0.069 | Calcium channel L-type blocker | |||
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.023 | 0.007 | 0.023 | G-protein-coupled receptor 120 agonist | |||
| 0.025 | 0.01 | 0.025 | Imidazoline I1 receptor antagonist | |||
| 0.05 | 0.035 | 0.05 | Prolyl endopeptidase inhibitor | |||
| 0.059 | 0.044 | 0.059 | Acetylcholine M5 receptor antagonist | |||
| 0.05 | 0.037 | 0.05 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.025 | 0.012 | 0.077 | Glutamate (mGluR1a) agonist | 0.077 0.004 CID_86290012 | CID_86290012 | |
| 0.033 | 0.02 | 0.033 | HCV NS5B polymerase inhibitor | |||
| 0.082 | 0.069 | 0.082 | Interleukin 5 antagonist | |||
| 0.05 | 0.038 | 0.05 | 5 Hydroxytryptamine 2 agonist | |||
| 0.07 | 0.057 | 0.212 | CDC25A inhibitor | 0.212 0.005 CID_86290012 | CID_86290012 | |
| 0.03 | 0.018 | 0.03 | Thiazolidinedione | 0.03 0.018 CID_86290012 | ||
| 0.027 | 0.015 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.049 | 0.037 | 0.049 | Potassium channel (Inward rectifier) activator | |||
| 0.03 | 0.018 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.016 | 0.005 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.019 | 0.008 | 0.019 | Thyroid hormone alpha antagonist | |||
| 0.049 | 0.037 | 0.049 | Thromboxane A2 antagonist | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.051 | 0.04 | 0.051 | Thromboxane antagonist | |||
| 0.047 | 0.036 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.104 | 0.093 | 0.104 | Nav1.3 sodium channel blocker | |||
| 0.076 | 0.066 | 0.076 | Phosphodiesterase IV inhibitor | |||
| 0.078 | 0.067 | 0.078 | Caspase 7 inhibitor | |||
| 0.111 | 0.1 | 0.111 | Toll-Like receptor antagonist | |||
| 0.042 | 0.032 | 0.042 | GABA B receptor antagonist | |||
| 0.015 | 0.005 | 0.015 | DNA polymerase III polC-type inhibitor | |||
| 0.025 | 0.015 | 0.037 | Glutamate (mGluR1) agonist | 0.037 0.006 CID_86290012 | CID_86290012 | |
| 0.03 | 0.02 | 0.03 | Complement C5a chemotactic receptor antagonist | |||
| 0.024 | 0.015 | 0.024 | CYP24 inhibitor | |||
| 0.058 | 0.049 | 0.058 | Glucagon-like peptide 1 agonist | |||
| 0.018 | 0.01 | 0.018 | Telomerase stimulant | |||
| 0.023 | 0.015 | 0.023 | Isoleucine-tRNA ligase inhibitor | |||
| 0.111 | 0.103 | 0.111 | Interleukin 1 antagonist | |||
| 0.034 | 0.026 | 0.034 | Progesterone antagonist | |||
| 0.026 | 0.018 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.102 | 0.094 | 0.102 | Glutamate receptor antagonist | |||
| 0.011 | 0.003 | 0.011 | DNA topoisomerase III inhibitor | |||
| 0.034 | 0.027 | 0.034 | Ceramide glucosyltransferase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Calcium-sensing receptor antagonist | |||
| 0.042 | 0.035 | 0.042 | Glutamate (mGluR group III) antagonist | |||
| 0.061 | 0.054 | 0.061 | Acetylcholine M5 receptor agonist | |||
| 0.059 | 0.052 | 0.059 | Neutrophil collagenase inhibitor | |||
| 0.06 | 0.054 | 0.06 | Neuronal nicotinic receptor antagonist | |||
| 0.061 | 0.055 | 0.061 | Cyclin B3 inhibitor | |||
| 0.047 | 0.042 | 0.047 | Ornithine carbamoyltransferase inhibitor | |||
| 0.032 | 0.027 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.021 | 0.016 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.035 | 0.03 | 0.035 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.127 | 0.123 | 0.127 | MAP kinase kinase 4 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Arginase inhibitor | |||
| 0.031 | 0.026 | 0.031 | Melatonin 2 agonist | |||
| 0.029 | 0.025 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.023 | 0.019 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.056 | 0.053 | 0.056 | Prostaglandin F2 alpha antagonist | |||
| 0.04 | 0.036 | 0.04 | Purinergic P2Y antagonist | |||
| 0.039 | 0.036 | 0.039 | Opioid kappa receptor agonist | |||
| 0.08 | 0.076 | 0.08 | Potassium channel activator | |||
| 0.059 | 0.056 | 0.115 | Neuraminidase (influenza) inhibitor | 0.115 0.013 CID_86290012 | CID_86290012 | |
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.033 | 0.031 | 0.033 | Kinesin-like protein 1 inhibitor | |||
| 0.033 | 0.031 | 0.033 | Kinesin antagonist | |||
| 0.076 | 0.074 | 0.076 | Histamine H2 receptor antagonist | |||
| 0.039 | 0.037 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.046 | 0.043 | 0.046 | Aldose reductase inhibitor | 0.045 0.043 CID_86290012 | ||
| 0.026 | 0.024 | 0.026 | Glucagon receptor antagonist | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.036 | 0.034 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.041 | 0.039 | 0.041 | Thymidylate synthase inhibitor | |||
| 0.034 | 0.032 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.035 | 0.033 | 0.035 | Kainate receptor antagonist | |||
| 0.025 | 0.024 | 0.025 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.011 | 0.01 | 0.011 | Glutamate (mGluR6) agonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.023 | 0.022 | 0.023 | Prostaglandin EP4 antagonist | |||
| 0.034 | 0.033 | 0.034 | TRPM8 blocker | |||
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.031 | 0.03 | 0.031 | Kainate receptor 2 antagonist | |||
| 0.029 | 0.028 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.061 | 0.06 | 0.061 | Elastase 1 inhibitor | |||
| 0.029 | 0.028 | 0.029 | Calcitonin receptor agonist | |||
| 0.069 | 0.073 | 0.116 | Chymotrypsin inhibitor | 0.116 0.027 CID_86290012 | CID_86290012 | |
| 0.025 | 0.034 | 0.044 | 1,3-Beta-glucan synthase inhibitor | 0.044 0.003 CID_86290012 | CID_86290012 | |
| 0.049 | 0.061 | 0.289 | Selectin antagonist | 0.289 0.006 CID_86290012 | CID_86290012 | |
| 0.031 | 0.045 | 0.113 | Dopamine D2 agonist | 0.113 0.009 CID_86290012 | CID_86290012 | |
| 0.11 | 0.123 | 0.238 | Thrombolytic | 0.238 0.037 CID_86290012 | CID_86290012 | |
| 0.014 | 0.028 | 0.181 | Estrone sulfatase inhibitor | 0.181 0.002 CID_86290012 | CID_86290012 | |
| 0.044 | 0.063 | 0.175 | Carbonic anhydrase inhibitor | 0.175 0.012 CID_86290012 | CID_86290012 | |
| 0.037 | 0.058 | 0.073 | Carbonic anhydrase II inhibitor | 0.073 0.028 CID_86290012 | CID_86290012 | |
| 0.043 | 0.067 | 0.075 | Neuraminidase inhibitor | 0.075 0.029 CID_86290012 | CID_86290012 | |
| 0.014 | 0.041 | 0.036 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.012 CID_86290012 | CID_86290012 | |
| 0.034 | 0.063 | 0.082 | Carbonic anhydrase I inhibitor | 0.082 0.024 CID_86290012 | CID_86290012 | |
| 0.028 | 0.059 | 0.064 | Carbonic anhydrase XII inhibitor | 0.064 0.031 CID_86290012 | CID_86290012 | |
| 0.036 | 0.074 | 0.135 | Factor IXa inhibitor | 0.135 0.005 CID_86290012 | CID_86290012 | |
| 0.022 | 0.064 | 0.078 | Purinergic P2Y2 antagonist | 0.078 0.005 CID_86290012 | CID_86290012 | |
| 0.024 | 0.069 | 0.054 | Carbonic anhydrase IX inhibitor | 0.054 0.04 CID_86290012 | CID_86290012 | |
| 0.128 | 0.173 | 0.181 | Platelet antagonist | 0.181 0.116 CID_86290012 | CID_86290012 | |
| 0.021 | 0.086 | 0.976 | Cholecystokinin B agonist | 0.976 0.001 CID_86290012 | CID_86290012 | |
| 0.007 | 0.072 | 0.866 | Cholecystokinin A agonist | 0.866 0.001 CID_86290012 | CID_86290012 | |
| 0.014 | 0.083 | 0.15 | NMDA 2D receptor antagonist | 0.15 0.003 CID_86290012 | CID_86290012 | |
| 0.007 | 0.076 | 0.885 | Cholecystokinin agonist | 0.885 0.001 CID_86290012 | CID_86290012 | |
| 0.028 | 0.108 | 0.081 | H+/K+-transporting ATPase inhibitor | 0.081 0.013 CID_86290012 | CID_86290012 | |
| 0.024 | 0.105 | 0.043 | Plasmin inhibitor | 0.043 0.036 CID_86290012 | CID_86290012 | |
| 0.053 | 0.135 | 0.074 | Cell adhesion molecule inhibitor | 0.074 0.062 CID_86290012 | CID_86290012 | |
| 0.025 | 0.121 | 0.154 | Elastase inhibitor | 0.154 0.004 CID_86290012 | CID_86290012 | |
| 0.032 | 0.131 | 0.055 | Autotaxin inhibitor | 0.055 0.033 CID_86290012 | CID_86290012 | |
| 0.043 | 0.148 | 0.059 | Trypsin inhibitor | 0.059 0.052 CID_86290012 | CID_86290012 | |
| 0.017 | 0.129 | 0.04 | Toll-Like receptor 4 agonist | 0.04 0.005 CID_86290012 | CID_86290012 | |
| 0.011 | 0.143 | 0.104 | Factor Xa inhibitor | 0.104 0.013 CID_86290012 | CID_86290012 | |
| 0.111 | 0.268 | 0.309 | Beta lactamase inhibitor | 0.309 0.131 CID_86290012 | CID_86290012 | |
| 0.136 | 0.296 | 0.44 | Antiobesity | 0.44 0.052 CID_86290012 | CID_86290012 | |
| 0.005 | 0.209 | 0.651 | Cholecystokinin A antagonist | 0.651 0.002 CID_86290012 | CID_86290012 | |
| 0.024 | 0.246 | 0.144 | Thrombin inhibitor | 0.144 0.012 CID_86290012 | CID_86290012 | |
| 0.004 | 0.238 | 0.578 | Cholecystokinin B antagonist | 0.578 0.002 CID_86290012 | CID_86290012 | |
| 0.005 | 0.256 | 0.599 | Cholecystokinin antagonist | 0.599 0.003 CID_86290012 | CID_86290012 | |
| 0.033 | 0.404 | 0.617 | Anticoagulant | 0.617 0.005 CID_86290012 | CID_86290012 | |
| 0.052 | 0.481 | 0.406 | Angiogenesis inhibitor | 0.406 0.052 CID_86290012 | CID_86290012 | |
| 0.003 | 0.441 | 0.017 | Sodium/hydrogen exchanger inhibitor | 0.017 0.013 CID_86290012 | CID_86290012 | |
| 0.004 | 0.599 | 0.049 | Factor XI inhibitor | 0.049 0.01 CID_86290012 | CID_86290012 | |
| 0.005 | 0.618 | 0.047 | Factor XIa inhibitor | 0.047 0.022 CID_86290012 | CID_86290012 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |